MED-EL recently rolled out the RONDO processor. Cochlear has just received FDA approval for the Nucleus 6. And AB is awaiting FDA approval for the Naída CI. Why isn’t the new hardware available as soon as it has been approved?
Two executives from Advanced Bionics offer some insight into the process of launching a new product, including the risks and challenges of getting the product to market as soon as possible.
Read more here.
Advanced Bionics announces regulatory approval from FDA, Health Canada, and TÜV for HiRes Optima.
HiRes Optima is a modification of the HiRes Fidelity 120 strategy, and is intended to optimize power efficiency. This new strategy improves battery life without compromising the listening benefits of the HiResolution bionic ear system. AB cochlear implant recipients using this new technology enjoy an average improvement of 55% in battery life, giving them considerably more time to hear their world before needing to change a battery.
Thanks to Bob MacPherson for breaking the news of FDA approval of the HiRes Optima sound processing strategy!
HiRes Optima is a modification of the HiRes Fidelity 120 strategy, and is intended to optimize power efficiency. This new strategy improves battery life without compromising the listening benefits of the HiResolution bionic ear system.
The Sonova Group, the parent company of Advanced Bionics, is conducting a survey. Parents of CI Kiddos of any make are welcome to participate. The company is especially looking for MED-EL users!
Calling all parents! Do you have a child with a cochlear implant? If so, the Sonova Group invites you to apply to participate in a study about pediatric cochlear implants. Those who qualify and complete the research project will receive a gift in appreciation of their participation. Sign up now! http://bit.ly/Yenz7D